Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 6.851
Filtrar
1.
Natl Med J India ; 37(2): 69-73, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39222534

RESUMEN

Background Membranous tonsillitis is one of the most common forms of acute tonsillitis in childhood. Although many different microorganisms may cause this disease, clinicians generally consider bacterial agents as a possible cause and prescribe a penicillin-group of antibiotic. This study aimed to determine the aetiology of membranous tonsillitis and prescribing errors. In addition, we investigated the effectiveness of epidemiological, clinical and laboratory parameters and their role in guiding treatment. Methods We did this retrospective study at the paediatric emergency department of a tertiary referral hospital including 423 outpatient children aged 0 to 18 years diagnosed with membranous tonsillitis. Results Group A beta-haemolytic streptococcus was found in 132 (31.2%) patients, Epstein-Barr virus (EBV) in 103 (24.3%), and other viral aetiologies in 188 (44.4%). The prescription rate of antibiotics in the EBV-positive group was 27%, and Downey cells were seen at a rate of 98% in this group. Only 7% of patients with a positive throat culture were started on appropriate antibiotics. Conclusion EBV and group A beta-haemolytic streptococcus were the most common causes of membranous tonsillitis. Throat culture and peripheral blood smears are the most useful tests for paediatric emergency clinicians; these are fast and can help ensure correct diagnosis and guide treatment in almost all patients.


Asunto(s)
Antibacterianos , Tonsilitis , Humanos , Tonsilitis/epidemiología , Tonsilitis/tratamiento farmacológico , Tonsilitis/microbiología , Preescolar , Niño , Estudios Retrospectivos , Adolescente , Lactante , Femenino , Masculino , Antibacterianos/uso terapéutico , Prevalencia , Pautas de la Práctica en Medicina/estadística & datos numéricos , Infecciones del Sistema Respiratorio/epidemiología , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Infecciones del Sistema Respiratorio/microbiología , Streptococcus pyogenes/aislamiento & purificación , Recién Nacido , Infecciones Estreptocócicas/epidemiología , Infecciones Estreptocócicas/tratamiento farmacológico
2.
BMC Pediatr ; 24(1): 503, 2024 Aug 06.
Artículo en Inglés | MEDLINE | ID: mdl-39107694

RESUMEN

BACKGROUND: The Finnish treatment guidelines for sore throat were updated in June 2020. The aim of this study was to determine how the publication of these guidelines affected the treatment of pediatric patients, particularly through the use of the Centor criteria, C-reactive protein tests, and microbiological testing in the diagnosis of Group A ß-hemolytic streptococci tonsillitis. METHODS: We conducted a retrospective single-center before-and-after cohort study in Finland from 2019 to 2022. We included all patients who visited the pediatric emergency department and were diagnosed with tonsillitis or pharyngitis. RESULTS: We included 246 patients who were admitted before the guidelines were updated and 219 patients after. Only two patients in the after group had a Centor score reported in their patient records. Rapid antigen tests were administered to 231 patients (93.9%) before the update and 202 patients (92.2%) after (proportion difference of 1.7%, CI -3.0-6.6%). C-reactive protein was taken from 193 patients (78.5%) before the update and 189 patients (86.3%) after (proportion difference of 7.8%, CI 0.1-14.7%). CONCLUSIONS: Centor scores were not used as recommended in the guidelines and did not impact the use of microbiological or C-reactive protein testing. More education and examining the preconceptions of health care personnel is required to implement the updated treatment guidelines in clinical practice.


Asunto(s)
Proteína C-Reactiva , Faringitis , Guías de Práctica Clínica como Asunto , Infecciones Estreptocócicas , Tonsilitis , Humanos , Faringitis/diagnóstico , Faringitis/microbiología , Estudios Retrospectivos , Niño , Masculino , Femenino , Proteína C-Reactiva/análisis , Finlandia , Infecciones Estreptocócicas/diagnóstico , Tonsilitis/diagnóstico , Tonsilitis/microbiología , Preescolar , Streptococcus pyogenes/aislamiento & purificación , Adolescente , Adhesión a Directriz/estadística & datos numéricos , Servicio de Urgencia en Hospital , Lactante
4.
Auris Nasus Larynx ; 51(5): 866-870, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39121558

RESUMEN

OBJECTIVE: To determine if perioperative administration of dexmedetomidine affects postoperative fluid intake in tonsillectomy patients. METHODS: A retrospective chart review was performed at University Medical Center, Texas Tech Health Science Center, Lubbock, Texas. The study identified 534 patients within the last five years who met the criteria. Common indications for the surgeries included recurrent tonsillitis, obstructive sleep apnea, and sleep disordered breathing. Patients with concurrent peritonsillar abscess drainage, microlaryngoscopy, bronchoscopy, supraglottoplasty, and other procedures that may impact fluid intake were excluded. The relationship between dexmedetomidine and fluid intake was evaluated using bivariate analysis as well as multivariable regression to account for possible confounders such as age, concurrent medication, surgery type, and method of surgery using STATA statistical software, version 17.0 (StataCorp LLC, College Station, TX). RESULTS: Administration of dexmedetomidine did not significantly impact the amount of fluid intake, fluid intake per kilogram per hour, or average postoperative pain levels in patients who underwent tonsillectomy or adenotonsillectomy in the bivariate analysis (p = 0.217, 0.489, 0.512 respectively) and multiple regression model (p = 0.156, 0.802, 0.795) CONCLUSION: Dexmedetomidine does not negatively influence postoperative fluid intake levels in patients and should continue to be utilized in appropriately selected patients experiencing anxiety or agitation prior to surgery.


Asunto(s)
Adenoidectomía , Deshidratación , Dexmedetomidina , Dolor Postoperatorio , Tonsilectomía , Humanos , Dexmedetomidina/administración & dosificación , Dexmedetomidina/uso terapéutico , Masculino , Femenino , Estudios Retrospectivos , Niño , Dolor Postoperatorio/tratamiento farmacológico , Preescolar , Adolescente , Adulto , Ingestión de Líquidos , Apnea Obstructiva del Sueño/cirugía , Adulto Joven , Tonsilitis/cirugía , Persona de Mediana Edad , Hipnóticos y Sedantes/uso terapéutico , Hipnóticos y Sedantes/administración & dosificación , Síndromes de la Apnea del Sueño
5.
Medicina (Kaunas) ; 60(8)2024 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-39202516

RESUMEN

Background and Objectives: Tonsillitis is common in children and is predominantly caused by viruses and, less frequently, by bacteria such as group A beta-hemolytic streptococcus. The treatment primarily involves supportive care; however, the overuse of antibiotics remains a concern due to rising antibiotic resistance. Probiotics, particularly Lactobacillus strains, have been shown to modulate immune responses, offering a potential alternative treatment. Materials and Methods: Our prospective single-arm, open-label study included 98 pediatric patients aged 5-15 years with recurrent throat and tonsil infections, from October 2022 to January 2023. Patients received lozenges containing heat-killed Lactobacillus helveticus MIMLh5. Monthly follow-ups involved a comprehensive ear, nose, and throat examination, throat cultures, and recording the frequency of infections and antibiotic use. Data were analyzed using SPSS 29.0, with statistical significance set at p < 0.05. Results: After three months, significant reductions were observed in the occurrences of nose and throat infections (p < 0.001), enlarged submandibular glands (p < 0.001), and positive throat cultures (p < 0.001). Antibiotic and corticosteroid prescriptions also significantly decreased (p < 0.001). Among children aged 5-10 years, significant improvements were noted in throat and tonsil infections (p < 0.001) and positive throat cultures (p = 0.012). Overall, there was a substantial reduction in school days missed (p < 0.001). Conclusions: The use of paraprobiotic Lactobacillus helveticus MIMLh5 lozenges significantly reduced the incidence of recurrent throat and tonsil infections in children, decreased the need for antibiotics and corticosteroids, and improved overall clinical outcomes without adverse effects. These findings support the use of paraprobiotic supplements as a safe and effective preventive measure for pediatric throat and tonsil infections.


Asunto(s)
Lactobacillus helveticus , Probióticos , Humanos , Niño , Femenino , Probióticos/uso terapéutico , Probióticos/administración & dosificación , Masculino , Preescolar , Estudios Prospectivos , Adolescente , Faringitis/microbiología , Faringitis/tratamiento farmacológico , Faringitis/prevención & control , Tonsilitis/tratamiento farmacológico , Tonsilitis/microbiología , Enfermedad Crónica , Resultado del Tratamiento , Antibacterianos/uso terapéutico , Antibacterianos/administración & dosificación
6.
Vestn Otorinolaringol ; 89(4): 20-25, 2024.
Artículo en Ruso | MEDLINE | ID: mdl-39171872

RESUMEN

Chronic tonsillitis remains as an urgent problem in modern otorhinolaryngological practice, which requires improving the diagnostic methods of this pathology. OBJECTIVE: To increase the diagnostic information content of objective methods for differential diagnosis of different forms of chronic tonsillitis. MATERIAL AND METHODS: The study involved 97 patients who were divided into two groups: the 1st group (39 patients) - with a simple form; the 2nd group (58 patients) - with a toxic-allergic form of chronic tonsillitis. To assess the structure of the palatine tonsils, patients underwent ultrasound in the compression elastography mode. RESULTS: According to results, patient with simple form of chronic tonsillitis in 64.1±7.68% cases had rigid structure of palatine tonsils, while toxic-allergic form is characterized by an elastic structure of the tonsils (58.62±6.47%). CONCLUSION: The ultrasound compression elastography helps to value efficiently the pathology of the palatine tonsils and conduct a differential diagnosis of clinical forms of chronic tonsillitis.


Asunto(s)
Diagnóstico por Imagen de Elasticidad , Tonsilitis , Humanos , Tonsilitis/diagnóstico por imagen , Tonsilitis/diagnóstico , Diagnóstico por Imagen de Elasticidad/métodos , Diagnóstico Diferencial , Masculino , Femenino , Enfermedad Crónica , Adulto , Persona de Mediana Edad , Reproducibilidad de los Resultados , Tonsila Palatina/diagnóstico por imagen
7.
Medicine (Baltimore) ; 103(27): e38798, 2024 Jul 05.
Artículo en Inglés | MEDLINE | ID: mdl-38968454

RESUMEN

RATIONALE: Descending necrotizing mediastinitis (DNM) is a rare but serious complication of oral and cervical infections that is associated with high mortality because diagnosis can be difficult or delayed. Early diagnosis and accurate identification of the causative pathogen can significantly reduce mortality, and are critical for the management of these patients. PATIENT CONCERNS: A 56-year-old female was admitted with a sore throat and fever. The initial diagnosis was acute tonsillitis, but she was transferred to the intensive care unit after developing dyspnea. DIAGNOSES: Pleural effusion and mediastinal lesions were detected by computed tomography, and a diagnosis of DNM was confirmed by laboratory tests. INTERVENTIONS: Initial treatment consisting of ceftriaxone and vancomycin with chest tube drainage were not effective. Thoracic surgery was performed to completely remove the "moss" tissue, blood clots, and pus. Next-generation sequencing was then performed, and the anti-infective treatment was changed to imipenem and linezolid based on these results. OUTCOMES: Eventually, the patient's symptoms were controlled, all vital signs were stable, and she was successfully transferred out of the intensive care unit. LESSONS: Next-generation sequencing is a rapid and accurate method for identification of pathogens that can provide a basis for early treatment of DNM, thereby improving patient prognosis and reducing mortality.


Asunto(s)
Secuenciación de Nucleótidos de Alto Rendimiento , Mediastinitis , Tonsilitis , Humanos , Femenino , Mediastinitis/diagnóstico , Mediastinitis/microbiología , Persona de Mediana Edad , Tonsilitis/complicaciones , Tonsilitis/microbiología , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Antibacterianos/uso terapéutico , Necrosis , Tomografía Computarizada por Rayos X , Enfermedad Aguda
8.
BMC Oral Health ; 24(1): 867, 2024 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-39080655

RESUMEN

BACKGROUND: Extranodal natural killer/T-cell lymphoma (ENKTL) with tonsil involvement is not common, especially in children. CASE PRESENTATION: A 13-year-old girl presented with an unexplained sore throat for more than 2 months, together with intermittent fever and suppurative tonsilitis. Nasopharyngoscopy revealed a pharyngeal mass. Enhanced computed tomography (CT) scan showed tonsillar hypertrophy and punctate calcification. Chronic pyogenic granulomatous inflammation with pseudoepithelial squamous epithelial hyperplasia was observed in left tonsil, and pyogenic granulomatous inflammation and a small number of T-lymphoid cells were detected in the right tonsil. The immunohistochemical results showed CD2+, CD3+, CD4+, CD5+, CD8+, granzyme B+, and TIA-1+. The Ki-67 proliferation index was 20%. The case showed T cell receptor gene rearrangement. Finally, the case was diagnosed as ENKTL of stage II with tonsil involvement. The patient received 6 cycles of chemotherapy with SMILE regimen, and showed complete response with no recurrence in the follow-up. CONCLUSION: We presented a rare case of ENKTL with tonsil involvement in a child. The patient showed complete response to the SMILE chemotherapy with no recurrence.


Asunto(s)
Linfoma Extranodal de Células NK-T , Neoplasias Tonsilares , Humanos , Femenino , Adolescente , Linfoma Extranodal de Células NK-T/patología , Neoplasias Tonsilares/patología , Neoplasias Tonsilares/diagnóstico por imagen , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Tonsila Palatina/patología , Tonsilitis/patología , Tonsilitis/tratamiento farmacológico , Tonsilitis/diagnóstico por imagen , Estudios de Seguimiento , Reordenamiento Génico de Linfocito T , Faringitis/patología , Vincristina/uso terapéutico , Tomografía Computarizada por Rayos X , Ciclofosfamida/uso terapéutico
9.
BMJ Open Qual ; 13(2)2024 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-38866589

RESUMEN

Patients referred by their general practitioner (GP) with a definite diagnosis, for example, recurrent sore throat for consideration of tonsillectomy in adults, may wait for months without receiving any further clinical information from the hospital until their outpatient consultation. Prompt provision of condition-specific information after referral has received little attention despite considerable potential to enhance patients' understanding, thereby relieving uncertainty and anxiety, and facilitating shared decision-making.This study aimed to report the experience of patients with recurrent tonsillitis who had been sent a booklet outlining the benefits and risks of tonsillectomy immediately after GP referral.Greater Glasgow and Clyde Health Board received 218 referrals of patients aged 16-40 to discuss tonsillectomy between January and August 2022. Every patient was sent a 16-page booklet by post and given the choice to opt in for a consultation.165 (76%) patients opted in, and 53 (24%) did not. Feedback was obtained from 143 patients (66%) from both groups. 99% found the information booklet easy to understand, 97% would recommend it to a friend with recurrent tonsillitis, 93% felt their questions had been answered and 92% believed it helped them to decide whether to proceed with tonsillectomy. Socioeconomic deprivation did not influence the outcome.In conclusion, most patients found provision of clinical information immediately after vetting of the referral to be beneficial, irrespective of whether they opted in for a consultation. This concept has broad applicability across all specialties, and the principles can be readily adopted and adapted by clinicians and managers in local units.


Asunto(s)
Derivación y Consulta , Tonsilectomía , Humanos , Tonsilectomía/métodos , Derivación y Consulta/estadística & datos numéricos , Derivación y Consulta/normas , Adulto , Femenino , Masculino , Adolescente , Tonsilitis/cirugía , Satisfacción del Paciente/estadística & datos numéricos , Adulto Joven , Encuestas y Cuestionarios
10.
Acta Microbiol Immunol Hung ; 71(2): 182-189, 2024 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-38941152

RESUMEN

The aim of this prospective pilot study was to compare culture and microbiome results of the removed tonsils of patients with assumed distant focal disease (11 patients) and those who underwent a tonsillectomy, due to other reasons, such as recurrent tonsillitis, tonsil stones or snoring (nine patients). Aerobic culture was carried out for samples taken from the surface of the tonsils by swabs before tonsillectomy for all 20 patients. The squeezed detritus and the tissue samples of removed tonsils, taken separately for the right and left tonsils, were incubated aerobically and anaerobically. The microbiome composition of tissue samples of removed tonsils was also evaluated. Based on the culture results of the deep samples Staphylococcus aureus was the dominating pathogen, besides a great variety of anaerobic and facultative anaerobic bacteria present in the oral microbiota in those patients who underwent tonsillectomy due to distant focal diseases. Microbiome study of the core tissue samples showed a great diversity on genus and species level among patients of the two groups however, S. aureus and Prevotella nigrescens were present in higher proportion in those, whose tonsils were removed due to distant focal diseases. Our results may support previous findings about the possible triggering role of S. aureus and P. nigrescens leading to distant focal diseases. Samples taken by squeezing the tonsils could give more information about the possible pathogenic/triggering bacteria than the surface samples cultured only aerobically.


Asunto(s)
Microbiota , Tonsila Palatina , Tonsilectomía , Tonsilitis , Humanos , Proyectos Piloto , Tonsila Palatina/microbiología , Estudios Prospectivos , Masculino , Femenino , Adulto , Tonsilitis/microbiología , Tonsilitis/cirugía , Niño , Adolescente , Adulto Joven , Bacterias/aislamiento & purificación , Bacterias/clasificación , Bacterias/genética , Staphylococcus aureus/aislamiento & purificación , Persona de Mediana Edad
11.
Przegl Epidemiol ; 78(1): 16-21, 2024 Jun 07.
Artículo en Inglés, Polaco | MEDLINE | ID: mdl-38904308

RESUMEN

Actinomycosis is a very rare, infectious disease, which is especially difficult to diagnose due to non-specific symptoms and the ability to emulate neoplasms or inflammatory changes. Due to those facts, it is often misdiagnosed or diagnosed too late to be successfully treated. This article presents the case of 31-year-old Caucasian female with recurrent upper respiratory tract infections and tonsillitis as the potential risk factors of actinomycosis. Upon examination of material collected through the course of tonsillectomy, the patient was diagnosed with actinomycosis of the left palatine tonsil. Despite the introduction of antibiotic therapy, initial progression was noted with the appearance of numerous, hypodense changes in the liver and the spleen, which regressed during further antibiotic treatment. According to our team's knowledge, this is the first described case of a patient with actinomycosis occurring simultaneously in the cervico-facial and abdominal area. The unusual localization and potential dissemination of actinomycosis should be considered in clinical practice.


Asunto(s)
Actinomicosis , Tonsilitis , Humanos , Femenino , Adulto , Actinomicosis/diagnóstico , Actinomicosis/tratamiento farmacológico , Tonsilitis/microbiología , Tonsilitis/tratamiento farmacológico , Tonsilitis/diagnóstico , Antibacterianos/uso terapéutico , Actinomicosis Cervicofacial/diagnóstico , Actinomicosis Cervicofacial/tratamiento farmacológico , Abdomen
12.
Ann Ital Chir ; 95(3): 330-337, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38918964

RESUMEN

AIM: Chronic tonsillitis (CT) is a very common ear, nose, and throat disease worldwide, and in severe cases it can cause sleep apnea hypoventilation syndrome, which can affect the patient's health and can even be life-threatening. Low-temperature plasma radiofrequency tonsillectomy is one of the commonly used methods for treating CT with remarkable results, but more detailed reports are lacking. In this study, we aimed to explore the impact of low-temperature plasma radiofrequency tonsillectomy on pain, inflammatory markers, and sleep quality in adult CT patients for clinical reference. METHODS: A retrospective study was performed on adult patients diagnosed with CT at our hospital between June 2019 and October 2023. Patients were categorized into a control group receiving traditional tonsillectomy and a treatment group undergoing low-temperature plasma radiofrequency tonsillectomy. The groups were compared in terms of baseline characteristics, surgical parameters, visual analogue scale (VAS) scores, 36-item short form (SF-36) health survey questionnaire scores, inflammatory markers, and Pittsburgh Sleep Quality Index (PSQI) scores. Group differences in postoperative complications were also analyzed. RESULTS: There were 160 patients, 80 in the treatment group (50 males and 30 females, mean age 28.90 ± 2.46 years) and 80 in the control group (46 males, 34 females, mean age 28.89 ± 2.01 years). Differences between the two groups in terms of age, sex, duration of disease, smoking history, body mass index, and other baseline characteristics were not statistically significant (p > 0.05). Operation time, intraoperative bleeding, return to normal diet, and pseudomembrane detachment time in the treatment group were all significantly lower than in the control group (p < 0.05). There were no significant differences in VAS or SF-36 scores before treatment (p > 0.05). Post-treatment, both groups had lower VAS scores and higher SF-36 scores in the treatment group compared to the control group (p < 0.05). There were no significant differences in levels of inflammatory markers before treatment (p > 0.05). Both groups showed increased levels of inflammatory markers post-treatment, but the treatment group had lower post-treatment levels of Interleukin-6 (IL-6) and hypersensitive-C reactive protein (hs-CRP) than the control group (p < 0.05). No significant difference was observed between the two groups in PSQI scores before treatment (p > 0.05). Following treatment, both groups had decreased PSQI scores, with lower scores in the treatment group than in the control group (p < 0.05). The complication rate was lower in the treatment group than in the control group, with rates of 8.75% and 23.75%, respectively (p < 0.05). CONCLUSIONS: Low-temperature plasma radiofrequency tonsillectomy for adult CT patients offers advantages such as shorter surgical time, reduced intraoperative bleeding, minimal trauma, and fewer postoperative complications. This procedure significantly alleviates pain, improves quality of life, reduces levels of inflammatory markers, and enhances sleep quality.


Asunto(s)
Calidad del Sueño , Tonsilectomía , Tonsilitis , Humanos , Tonsilitis/cirugía , Tonsilitis/sangre , Tonsilitis/complicaciones , Masculino , Femenino , Adulto , Estudios Retrospectivos , Enfermedad Crónica , Biomarcadores/sangre , Dimensión del Dolor , Inflamación/sangre
13.
Int J Mol Sci ; 25(10)2024 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-38791337

RESUMEN

Tonsillectomy with steroid pulse therapy (SPT) has been established as an effective treatment for immunoglobulin A nephropathy (IgAN) in Japan. However, the underlying mechanisms supporting tonsillectomy remain unclear. This study assessed palatine tonsils from 77 patients with IgAN, including 14 and 63 who received SPT before and after tonsillectomy, respectively. Tonsils from 21 patients with chronic tonsillitis were analyzed as controls. Specific tonsillar lesions were confirmed in patients with IgAN, correlating with active or chronic renal glomerular lesions and SPT. T-nodule and involution of lymphoepithelial symbiosis scores in tonsils correlated with the incidence of active crescents and segmental sclerosis in the glomeruli, respectively. The study revealed an essential role of the tonsil-glomerular axis in early active and late chronic phases. Moreover, the SPT-preceding group demonstrated no changes in the T-nodule score, which correlated with active crescent formation, but exhibited a considerable shrinkage of lymphatic follicles that produced aberrant IgA1. The study underscores the involvement of innate and cellular immunity in IgAN and advocates for tonsillectomy as a necessary treatment alongside SPT for IgAN, based on a stepwise process.


Asunto(s)
Glomerulonefritis por IGA , Glomérulos Renales , Tonsila Palatina , Tonsilectomía , Humanos , Glomerulonefritis por IGA/patología , Glomerulonefritis por IGA/cirugía , Tonsila Palatina/cirugía , Tonsila Palatina/patología , Femenino , Masculino , Adulto , Glomérulos Renales/patología , Estudios Retrospectivos , Persona de Mediana Edad , Tonsilitis/cirugía , Tonsilitis/patología , Adulto Joven , Inmunoglobulina A
14.
JMIR Res Protoc ; 13: e53703, 2024 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-38819917

RESUMEN

BACKGROUND: A dietary supplement containing Pelargonium sidoides extract, propolis, zinc, and honey has been recently developed and proven to be an effective adjuvant in clinical practice for seasonal diseases and the treatment of respiratory tract disorders. OBJECTIVE: This trial aims to verify the efficacy of the tested dietary supplement in a pediatric population with acute tonsillopharyngitis/rhinopharyngitis (ATR). METHODS: The trial includes children aged between 3 and 10 years with ATR ≤48 h, a negative rapid test for beta-hemolytic streptococcus or culture identification of nasal and/or pharyngeal exudates, and SARS-CoV-2 infection. The dietary supplement tested is an oral solution already on the market based on Pelagon P-70 (equivalent to Pelargonium sidoides d.e. 133.3 mg/100 ml), propolis, zinc, and honey. The product is administered at 5 ml 3 times a day for 6 days for children younger than 6 years and 10 ml 3 times a day for 6 days for children older than 6 years. The study design is open label, randomized, and controlled, with the tested dietary supplement plus standard of care (SoC) versus SoC alone. Patients are enrolled from 3 sites in Romania. The change in Tonsillitis Severity Score and number of treatment failures (using ibuprofen or high-dose paracetamol as rescue medication) are the primary end points. Based on the Tonsillitis Severity Score and the 2-sample comparison of the means formula with a 5% significance level, 80% power, and a minimally clinically important difference of 2 (SD 3.85) points, 120 patients are required. To account for potential screening failures and dropouts, we need to screen a population of approximately 150 children. RESULTS: Patient enrollment began on June 3, 2021 (first patient's first visit), and ended on August 12, 2021 (last patient's last visit). The data collection period was from June 3, 2021, to September 16, 2021. The study was funded in February 2023. Data analysis is currently ongoing (April 2024). We expect the results to be published in a peer-reviewed clinical journal in the third quarter of 2024 and presented at scientific meetings in the last quarter of 2024. CONCLUSIONS: The data from this trial may help identify new adjuvant treatments for children with ATR when streptococcal infection is excluded by a negative rapid test, thereby avoiding unnecessary antibiotic administration. TRIAL REGISTRATION: ClinicalTrials.gov NCT04899401 https://clinicaltrials.gov/study/NCT04899401. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/53703.


Asunto(s)
Suplementos Dietéticos , Miel , Faringitis , Tonsilitis , Niño , Preescolar , Femenino , Humanos , Masculino , Enfermedad Aguda , COVID-19 , Faringitis/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Extractos Vegetales/administración & dosificación , Própolis/uso terapéutico , Própolis/administración & dosificación , Ensayos Clínicos Controlados Aleatorios como Asunto , Nivel de Atención , Tonsilitis/tratamiento farmacológico , Tonsilitis/microbiología , Zinc/uso terapéutico , Zinc/administración & dosificación
15.
Int J Pediatr Otorhinolaryngol ; 181: 111942, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38723424

RESUMEN

OBJECTIVES: Coblation intracapsular tonsillectomy (ICT) is increasingly being used in the paediatric population because of the rapid recovery and low rates of complications associated with it. There is, however, a risk of symptomatic regrowth with this technique. The objective of our study is to establish the rate of, and risks for, revision surgery over time in a major tertiary referral centre with a large cohort of paediatric Coblation ICT cases. METHODS: A retrospective review of all children (0-19 years) undergoing Coblation ICT from April 2013 to June 2022 was undertaken, using electronic databases and clinical records. Post-operative follow up was reviewed and revision cases were subsequently identified and examined. Statistical analysis was performed using a Chi-Squared test. RESULTS: 4111 patients underwent Coblation ICT during the studied period, with or without concomitant adenoidectomy. Of these, 135 (3.3 %) required revision tonsil surgery, primarily for recurrence of initial symptoms; two patients required two consecutive revision procedures (137 revision procedures in total). Eight-eight (n = 88) (64 %) of these were revised with a repeat Coblation ICT procedure and 49 (36 %) with bipolar diathermy extracapsular tonsillectomy (ECT) of remnant tonsil tissue. The revision rates after Coblation ICT declined steeply on a year-on-year basis since the commencement of this technique (from 10.6 % early on, to 0.3 % at the end of the study period P<0.001). A significantly higher revision rate was noted in children below the age of two at the time of primary surgery, compared to those older than two years of age (P<0.001). CONCLUSIONS: This study demonstrates real-world departmental revision rates over a nine-year period from the technique's commencement of use. With Coblation ICT, symptomatic re-growth occurs rarely, but may be clinically significant, with higher rates of recurrent symptoms seen in children under two years of age at the time of primary surgery. The revision rate apparently drops over time in parallel with overall experience of surgeons and formalised training.


Asunto(s)
Reoperación , Centros de Atención Terciaria , Tonsilectomía , Humanos , Tonsilectomía/métodos , Tonsilectomía/estadística & datos numéricos , Reoperación/estadística & datos numéricos , Niño , Estudios Retrospectivos , Femenino , Masculino , Preescolar , Adolescente , Lactante , Tonsilitis/cirugía , Adulto Joven , Recurrencia , Resultado del Tratamiento , Recién Nacido
16.
Ter Arkh ; 96(3): 273-279, 2024 Apr 16.
Artículo en Ruso | MEDLINE | ID: mdl-38713043

RESUMEN

BACKGROUND: Acute tonsillopharyngitis is one of the most common types of respiratory tract infections. In case of bacterial etiologies of the disease, penicillin antibiotics are prescribed, in particular amoxicillin + clavulanic acid. Dispersible forms of antibiotics have a number of advantages over film-coated tablets and are characterized by better pharmacokinetic parameters that increase the effectiveness and safety of treatment, as well as patient compliance. AIM: To compare the effectiveness and safety of Amoxicillin + Clavulanic acid EXPRESS in the form of dispersible tablets and amoxicillin with clavulanic acid in film-coated tablets in the treatment of acute streptococcal tonsillopharyngitis. MATERIALS AND METHODS: A randomized comparative clinical study involved 60 adult patients diagnosed with acute streptococcal tonsillopharyngitis. Group 1 (n=30) received the Amoxicillin + Clavulanic acid EXPRESS, dispersible tablets, 875+125 mg 2 times a day at the beginning of meals. Group 2 (n=30) received Amoxiclav, film-coated tablets, 875+125 mg 2 times a day at the beginning of meals. The duration of the treatment was 10 days. The following procedures were performed to all participants: general clinical and otorhinolaryngological examinations, an express test to detect group A streptococcal antigens in a smear from the posterior pharyngeal wall (streptatest), assessment of symptoms of acute tonsillopharyngitis on the McIsaac scale, severity of sore throat, difficulty swallowing, swelling of the throat, measurement of body temperature, assessment of the clinical global impression of the therapy, adherence to treatment, frequency of the adverse reactions before treatment, 3 days after the beginning of therapy and after the course completion (day 10). RESULTS: Recovery occurred in 96.6% of patients in group 1 according to examination on the 10th day of treatment and in 93.3% of patients in group 2. The rate of fever regression was higher in group 1 - on the 3rd day of treatment, normalization of temperature was observed in 36.6% and 30% of patients in the comparison group. Pain syndrome, symptoms of throat swelling and difficulty swallowing significantly (p<0.01) regressed by the 10th day in patients of both treatment groups. The incidence of adverse reactions on the 10th day of treatment in group 1 was 10%, in group 2 - 33.3% (p=0.03). CONCLUSION: Amoxicillin + Clavulanic acid EXPRESS has high therapeutic efficacy in the treatment of acute streptococcal tonsillopharyngitis, comparable to the Amoxiclav in film-coated tablets. At the same time, dispersible tablets of Amoxicillin + Clavulanic acid EXPRESS demonstrated a significantly higher safety profile compared to the simple tablet form.


Asunto(s)
Combinación Amoxicilina-Clavulanato de Potasio , Antibacterianos , Faringitis , Infecciones Estreptocócicas , Tonsilitis , Humanos , Masculino , Femenino , Adulto , Infecciones Estreptocócicas/tratamiento farmacológico , Infecciones Estreptocócicas/microbiología , Faringitis/tratamiento farmacológico , Faringitis/microbiología , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Tonsilitis/tratamiento farmacológico , Tonsilitis/microbiología , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Enfermedad Aguda , Resultado del Tratamiento , Persona de Mediana Edad
17.
PLoS One ; 19(5): e0301853, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38709804

RESUMEN

BACKGROUND: Altered immunological responses in the palatine tonsils may be involved in the pathogenesis of IgA nephropathy (IgAN). The germinal center serves as the site for antigen-specific humoral immune responses in the palatine tonsils. Germinal center involution is frequently observed in the palatine tonsils of IgAN (IgAN tonsils). However, the pathogenic significance of these characteristic changes remains unclear. This study aimed to investigate the morphological changes in secondary lymphoid follicles in IgAN tonsils and to evaluate the correlation between the morphometric results and the clinicopathological severity of IgAN. METHODS: The tonsils of age-matched patients with recurrent tonsillitis (RT tonsils) were used as controls. The correlation between the degree of lymphoid follicular involution and histopathological severities in clinical or kidney biopsy was evaluated. RESULTS: In total, 87 patients with IgAN were included (48% male, median age 35 years, median estimated glomerular filtration rate: 74 mL/min/1.73 m2). Compared to RT tonsils, IgAN tonsils showed smaller median sizes of lymphoid follicles and germinal centers (P < 0.001). The relative areas of lymphoid follicles (%LFA) and germinal centers (%GCA) in the total tonsillar tissue were smaller in the IgAN tonsils than in the RT tonsils (P < 0.001). In contrast, the median proportion of mantle zones in the total tonsillar tissue was comparable between the groups. A lower %LFA was associated with a longer period from the onset of urinary abnormalities to biopsy diagnosis and higher urinary protein excretion (P = 0.01). %LFA showed significant negative correlations with frequencies of glomeruli with both global and segmental sclerosis. CONCLUSIONS: The present study confirmed accelerated germinal center involution in the tonsils of patients with IgAN. This characteristic change in the IgAN tonsil correlates with heavy proteinuria and advanced chronic histopathological changes in the kidneys, thereby suggesting the involvement of repeated tonsillar immunoreactions during IgAN progression.


Asunto(s)
Centro Germinal , Glomerulonefritis por IGA , Tonsila Palatina , Humanos , Glomerulonefritis por IGA/patología , Glomerulonefritis por IGA/inmunología , Tonsila Palatina/patología , Tonsila Palatina/inmunología , Centro Germinal/inmunología , Centro Germinal/patología , Masculino , Femenino , Adulto , Tonsilitis/patología , Tonsilitis/inmunología , Persona de Mediana Edad , Adulto Joven , Riñón/patología , Riñón/inmunología
18.
Eur J Clin Microbiol Infect Dis ; 43(6): 1099-1107, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38609699

RESUMEN

OBJECTIVES: Fusobacterium necrophorum is a common cause of pharyngotonsillitis. However, no guidelines exist on when to diagnose or treat it. We aimed to investigate associations between clinical criteria and F. necrophorum-positivity in pharyngotonsillitis and assess the predictive potential of a simple scoring system. METHODS: Pharyngotonsillitis patients who were tested for F. necrophorum (PCR) and presented to hospitals in the Skåne Region, Sweden, between 2013-2020 were eligible. Data were retrieved from electronic chart reviews and registries. By logistic regression we investigated associations between F. necrophorum-positivity and pre-specified criteria: age 13-30 years, symptom duration ≤ 3 days, absence of viral symptoms (e.g. cough, coryza), fever, tonsillar swelling/exudate, lymphadenopathy and CRP ≥ 50 mg/L. In secondary analyses, associated variables were weighted by strength of association into a score and its predictive accuracy of F. necrophorum was assessed. RESULTS: Among 561 cases included, 184 (33%) had F. necrophorum, which was associated with the following criteria: age 13-30, symptom duration ≤ 3 days, absence of viral symptoms, tonsillar swelling/exudate and CRP ≥ 50 mg/L. Age 13-30 had the strongest association (OR5.7 95%CI 3.7-8.8). After weighting, these five variables had a sensitivity and specificity of 68% and 71% respectively to predict F. necrophorum-positivity at the proposed cut-off. CONCLUSION: Our results suggest that F. necrophorum cases presenting to hospitals might be better distinguished from other pharyngotonsillitis cases by a simple scoring system presented, with age 13-30 being the strongest predictor for F. necrophorum. Prospective studies, involving primary care settings, are needed to evaluate generalisability of findings beyond cases presenting to hospitals.


Asunto(s)
Infecciones por Fusobacterium , Fusobacterium necrophorum , Faringitis , Tonsilitis , Humanos , Fusobacterium necrophorum/aislamiento & purificación , Suecia/epidemiología , Infecciones por Fusobacterium/diagnóstico , Infecciones por Fusobacterium/microbiología , Masculino , Adolescente , Femenino , Adulto , Tonsilitis/microbiología , Tonsilitis/diagnóstico , Adulto Joven , Faringitis/microbiología , Faringitis/diagnóstico , Persona de Mediana Edad , Hospitales , Anciano
20.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA